+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Urolithin B Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125263
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Urolithin B Market is projected to reach USD 854.41 Million in 2026. It is expected to continue growing at a CAGR of 10.88%, reaching USD 1.60 Billion by 2032.

Urolithin B: Executive Summary and Market Context

Urolithin B is a gut microbiota-derived metabolite associated with the transformation of ellagitannins and ellagic acid, compounds found in foods such as pomegranates, berries, and nuts. Interest centers on its potential relevance to mitochondrial function, muscle biology, inflammation, and healthy aging. The field remains scientifically developing, with product, clinical, regulatory, and formulation considerations shaping commercialization pathways.

Scientific Translation Is Reshaping Urolithin B Development

The landscape is shifting from broad nutraceutical positioning toward more defined evidence generation. Researchers are examining bioavailability, metabolism, mechanisms of action, safety, and the role of individual gut microbiome profiles in determining exposure. Product developers are also evaluating standardized ingredients, delivery systems, quality controls, and substantiated claims. These shifts increase the importance of reproducible analytical methods and well-designed human studies.

Artificial Intelligence Accelerates Discovery, Validation, and Personalization

Artificial intelligence can support Urolithin B research by integrating metabolomics, microbiome, pharmacokinetic, and clinical datasets to identify response patterns and generate hypotheses. Machine-learning tools may assist with formulation screening, biomarker selection, trial recruitment, and adverse-event monitoring. However, model quality depends on representative datasets, transparent validation, privacy safeguards, and experimental confirmation. AI should therefore complement, rather than replace, laboratory and clinical evidence.

Regional Insights: Regulation, Research Capacity, and Consumer Priorities Differ

North America is characterized by advanced supplement research, clinical infrastructure, and strong interest in healthy aging, while Latin America combines botanical food traditions with developing regulatory and research capabilities. Europe emphasizes evidence standards, novel-food and health-claim requirements, sustainability, and traceability. The Middle East is seeing growing attention to preventive health and specialized nutrition, whereas Africa presents opportunities linked to nutrition science and local research capacity but also infrastructure constraints. Asia-Pacific combines substantial nutraceutical activity, established traditional-health systems, expanding biotechnology capabilities, and varied regulatory frameworks across markets.

Group Insights: Economic and Policy Blocs Shape Access and Collaboration

ASEAN markets reflect diverse supplement rules, trade practices, and consumer preferences, making regional harmonization important. BRICS members offer broad research, manufacturing, and consumer ecosystems but require careful navigation of differing evidence and registration systems. The European Union places strong emphasis on coordinated food, safety, and claims frameworks. G7 economies generally provide advanced research and regulatory infrastructure, while GCC markets emphasize import compliance, quality assurance, and premium preventive-health positioning. NATO countries are not a single regulatory bloc, but their combined research, procurement, and public-health networks can support scientific collaboration and resilience in specialized supply chains.

Country Insights: National Priorities Influence Research and Commercialization

Australia combines strong complementary-medicine expertise with regulated therapeutic-goods pathways. Brazil and Mexico have substantial nutraceutical demand and distinctive food and biodiversity contexts, alongside complex compliance requirements. Canada and the United States support active nutrition and aging research, with claims and product classification requiring careful substantiation. China, Japan, and South Korea have sophisticated functional-food and biotechnology ecosystems, while India combines pharmaceutical capability with traditional-health knowledge and a large nutrition market. France, Germany, Italy, Spain, and the United Kingdom emphasize safety, scientific evidence, quality, and varying national implementation of European requirements. Russia requires attention to its distinct regulatory and trade environment.

Recommendations for Leaders: Build Evidence, Quality, and Regulatory Readiness

Industry leaders should prioritize mechanism-informed human research, clearly defined populations, validated biomarkers, and transparent reporting of safety and tolerability. They should establish specifications for identity, purity, stability, contaminants, and batch consistency, while mapping product classification and claims requirements before entering each jurisdiction. Partnerships with microbiome, metabolomics, clinical, and formulation specialists can reduce development risk. Responsible communication should distinguish established findings from exploratory evidence, and AI applications should include governance, bias testing, cybersecurity, and independent validation.

Research Methodology: Evidence-Led Assessment of Urolithin B

This executive summary uses a structured review framework covering peer-reviewed scientific literature, human and preclinical research, regulatory materials, technical quality considerations, and publicly documented regional and country-level conditions. Evidence is assessed by study design, relevance, reproducibility, and consistency across sources. Regional, group, and country comparisons focus on research capacity, regulatory context, consumer-health priorities, and commercialization conditions. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Scientific Discipline Will Define Urolithin B’s Next Stage

Urolithin B occupies an emerging position at the intersection of microbiome science, nutrition, mitochondrial biology, and healthy aging. Its progress will depend less on broad promotional claims than on reproducible manufacturing, credible human evidence, appropriate regulatory pathways, and careful interpretation of individual biological variation. Organizations that combine rigorous science with transparent communication and region-specific execution will be best positioned to advance the field responsibly.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Urolithin B Market, by Application
7.1. Introduction
7.2. Cosmetics & Personal Care
7.3. Dietary Supplements
7.4. Functional Foods & Beverages
7.5. Pharmaceuticals
8. Urolithin B Market, by Form
8.1. Introduction
8.2. Capsule
8.3. Liquid
8.4. Powder
8.5. Tablet
9. Urolithin B Market, by Source
9.1. Introduction
9.2. Biofermented
9.3. Synthetic
10. Urolithin B Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Online
10.4. Specialty Stores
11. Urolithin B Market, by End User
11.1. Introduction
11.2. Cosmetic Manufacturers
11.3. Dietary Supplement Manufacturers
11.4. Pharmaceutical Companies
11.5. Research Institutions
12. Urolithin B Market, by Grade
12.1. Introduction
12.2. Cosmetic Grade
12.3. Food Grade
12.4. Pharmaceutical Grade
12.5. Standard Grade
13. Urolithin B Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Urolithin B Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Urolithin B Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bio-Botanica Inc.
17.2. Cayman Chemical Company
17.3. Hangzhou Ark Biotechnology Co., Ltd.
17.4. Indena S.p.A.
17.5. International Flavors & Fragrances Inc.
17.6. Merck KGaA
17.7. Nutraveris SAS
17.8. PLT Health Solutions Ltd.
17.9. Sabinsa Corporation
17.10. Toronto Research Chemicals Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Urolithin B Market, Years Considered for the Study
FIGURE 2. Global Urolithin B Market, Research Design
FIGURE 3. Global Urolithin B Market, Research Framework
FIGURE 4. Global Urolithin B Market, Data Triangulation
FIGURE 5. Global Urolithin B Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Urolithin B Market Size, by Application, 2025 vs 2032 (%)
FIGURE 7. Global Urolithin B Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Urolithin B Market Size, by Form, 2025 vs 2032 (%)
FIGURE 9. Global Urolithin B Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Urolithin B Market Size, by Source, 2025 vs 2032 (%)
FIGURE 11. Global Urolithin B Market Size, by Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Urolithin B Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Urolithin B Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Urolithin B Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Urolithin B Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Urolithin B Market Size, by Grade, 2025 vs 2032 (%)
FIGURE 17. Global Urolithin B Market Size, by Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Urolithin B Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Urolithin B Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Urolithin B Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Urolithin B Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Urolithin B Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Urolithin B Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Urolithin B Market Segmentation & Coverage
TABLE 2. Global Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 3. Global Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 4. Global Cosmetics & Personal Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cosmetics & Personal Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cosmetics & Personal Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dietary Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dietary Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dietary Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Functional Foods & Beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Functional Foods & Beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Functional Foods & Beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 17. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 30. Global Biofermented Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Biofermented Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Biofermented Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 37. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Specialty Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Specialty Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Specialty Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Cosmetic Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cosmetic Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cosmetic Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Dietary Supplement Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Dietary Supplement Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Dietary Supplement Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 60. Global Cosmetic Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Cosmetic Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Cosmetic Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Food Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Food Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Food Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pharmaceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pharmaceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pharmaceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Standard Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Standard Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Standard Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 80. North America Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. North America Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. North America Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 83. North America Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 84. North America Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. North America Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. North America Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 87. Latin America Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Latin America Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Latin America Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 90. Latin America Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 91. Latin America Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Latin America Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Latin America Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 94. Europe Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Europe Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Europe Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 97. Europe Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 98. Europe Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Europe Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Europe Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 101. Middle East Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Middle East Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Middle East Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 104. Middle East Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 105. Middle East Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Middle East Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Middle East Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 108. Africa Urolithin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Africa Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Africa Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 111. Africa Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 112. Africa Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. Africa Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Africa Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 115. Global Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. ASEAN Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 119. ASEAN Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 120. ASEAN Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. ASEAN Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. ASEAN Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 123. GCC Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. GCC Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 126. GCC Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 127. GCC Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. GCC Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. GCC Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 130. European Union Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. European Union Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. European Union Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 133. European Union Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 134. European Union Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. European Union Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. European Union Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 137. BRICS Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. BRICS Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. BRICS Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 140. BRICS Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 141. BRICS Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. BRICS Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. BRICS Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 144. G7 Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. G7 Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. G7 Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 147. G7 Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 148. G7 Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. G7 Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. G7 Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 151. NATO Urolithin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. NATO Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. NATO Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 154. NATO Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 155. NATO Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. NATO Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. NATO Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 158. Global Urolithin B Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 160. United States Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. United States Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 162. United States Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 163. United States Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. United States Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. United States Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 166. Canada Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Canada Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 169. Canada Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 170. Canada Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Canada Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Canada Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 173. Mexico Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 174. Mexico Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Mexico Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 176. Mexico Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 177. Mexico Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Mexico Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Mexico Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 180. Brazil Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 181. Brazil Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Brazil Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 183. Brazil Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 184. Brazil Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. Brazil Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Brazil Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 187. United Kingdom Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 188. United Kingdom Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. United Kingdom Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 190. United Kingdom Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 191. United Kingdom Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. United Kingdom Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. United Kingdom Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 194. Germany Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 195. Germany Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Germany Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 197. Germany Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 198. Germany Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Germany Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Germany Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 201. France Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 202. France Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. France Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 204. France Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 205. France Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. France Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. France Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 208. Russia Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 209. Russia Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Russia Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 211. Russia Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 212. Russia Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Russia Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Russia Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 215. Italy Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 216. Italy Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Italy Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 218. Italy Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 219. Italy Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Italy Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Italy Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 222. Spain Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 223. Spain Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Spain Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 225. Spain Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 226. Spain Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. Spain Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Spain Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 229. China Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 230. China Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. China Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 232. China Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 233. China Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. China Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. China Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 236. India Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 237. India Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. India Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 239. India Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 240. India Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. India Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. India Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 243. Japan Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 244. Japan Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Japan Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 246. Japan Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 247. Japan Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. Japan Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Japan Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 250. Australia Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 251. Australia Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Australia Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 253. Australia Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 254. Australia Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Australia Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Australia Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 257. South Korea Urolithin B Market Size, 2017-2032 (USD Million)
TABLE 258. South Korea Urolithin B Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. South Korea Urolithin B Market Size, by Form, 2017-2032 (USD Million)
TABLE 260. South Korea Urolithin B Market Size, by Source, 2017-2032 (USD Million)
TABLE 261. South Korea Urolithin B Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. South Korea Urolithin B Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. South Korea Urolithin B Market Size, by Grade, 2017-2032 (USD Million)
TABLE 264. Global Urolithin B Market Share, by Key Player, 2025
TABLE 265. Global Urolithin B Market, Key Experts

Companies Mentioned

  • Bio-Botanica Inc.
  • Cayman Chemical Company
  • Hangzhou Ark Biotechnology Co., Ltd.
  • Indena S.p.A.
  • International Flavors & Fragrances Inc.
  • Merck KGaA
  • Nutraveris SAS
  • PLT Health Solutions Ltd.
  • Sabinsa Corporation
  • Toronto Research Chemicals Inc.